Literature DB >> 12946328

In vivo and in vitro demonstration that Staphylococcus aureus is an intracellular pathogen in the presence or absence of fibronectin-binding proteins.

Eric Brouillette1, Gilles Grondin, Lulzim Shkreta, Pierre Lacasse, Brian G Talbot.   

Abstract

Staphylococcus aureus is the most significant bacterial pathogen associated with bovine mastitis. However, the relevance of intracellular infection to mastitis pathogenesis is poorly understood. We used in vitro assays and a mouse model of mastitis to demonstrate the intracellular component of the infection and to identify the importance of fibronectin-binding proteins in the processes of colonization and internalization. In vitro, a mutant strain, lacking fibronectin-binding protein (FnBPs(-)), had a reduced ability to bind fibronectin and to infect epithelial cells when compared to its parental wild type strain. After 2 h of infection, the internalization of the mutant bacteria into epithelial cell cultures was reduced by 60% compared with the wild type. After in vivo infection, microscopic examination using the FnBPs(-) strain revealed that production of a high density of live bacteria within the mammary gland epithelial cells was delayed. Both parental and mutant strains were identified within neutrophils, macrophages and epithelial cells suggesting a close similarity between the mouse mastitis model and bovine mastitis. These results demonstrate that S. aureus was able to cause an intracellular infection in the mouse model of mastitis and that the elimination of one adhesion protein delayed, but did not prevent, infection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12946328     DOI: 10.1016/s0882-4010(03)00112-8

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  33 in total

1.  Activity of a novel protonophore against methicillin-resistant Staphylococcus aureus.

Authors:  Nagendran Tharmalingam; Elamparithi Jayamani; Rajmohan Rajamuthiah; Dawilmer Castillo; Beth Burgwyn Fuchs; Michael J Kelso; Eleftherios Mylonakis
Journal:  Future Med Chem       Date:  2017-08-03       Impact factor: 3.808

Review 2.  Adhesion, invasion and evasion: the many functions of the surface proteins of Staphylococcus aureus.

Authors:  Timothy J Foster; Joan A Geoghegan; Vannakambadi K Ganesh; Magnus Höök
Journal:  Nat Rev Microbiol       Date:  2014-01       Impact factor: 60.633

3.  Enhanced post-stationary-phase survival of a clinical thymidine-dependent small-colony variant of Staphylococcus aureus results from lack of a functional tricarboxylic acid cycle.

Authors:  Indranil Chatterjee; Mathias Herrmann; Richard A Proctor; Georg Peters; Barbara C Kahl
Journal:  J Bacteriol       Date:  2007-01-26       Impact factor: 3.490

4.  Intra- and extracellular activities of dicloxacillin and linezolid against a clinical Staphylococcus aureus strain with a small-colony-variant phenotype in an in vitro model of THP-1 macrophages and an in vivo mouse peritonitis model.

Authors:  Anne Sandberg; Sandrine Lemaire; Françoise Van Bambeke; Paul M Tulkens; Diarmaid Hughes; Christof von Eiff; Niels Frimodt-Møller
Journal:  Antimicrob Agents Chemother       Date:  2011-01-31       Impact factor: 5.191

5.  Heparan sulfate proteoglycans mediate Staphylococcus aureus interactions with intestinal epithelium.

Authors:  Donavon J Hess; Michelle J Henry-Stanley; Stanley L Erlandsen; Carol L Wells
Journal:  Med Microbiol Immunol       Date:  2005-12-24       Impact factor: 3.402

6.  Antimicrobial activities of daptomycin, vancomycin, and oxacillin in human monocytes and of daptomycin in combination with gentamicin and/or rifampin in human monocytes and in broth against Staphylococcus aureus.

Authors:  Aldona L Baltch; William J Ritz; Lawrence H Bopp; Phyllis B Michelsen; Raymond P Smith
Journal:  Antimicrob Agents Chemother       Date:  2007-02-05       Impact factor: 5.191

7.  Induction of virulence gene expression in Staphylococcus aureus by pulmonary surfactant.

Authors:  Kenichi Ishii; Tatsuo Adachi; Jyunichiro Yasukawa; Yutaka Suzuki; Hiroshi Hamamoto; Kazuhisa Sekimizu
Journal:  Infect Immun       Date:  2014-01-22       Impact factor: 3.441

8.  Cellular pharmacodynamics of the novel biaryloxazolidinone radezolid: studies with infected phagocytic and nonphagocytic cells, using Staphylococcus aureus, Staphylococcus epidermidis, Listeria monocytogenes, and Legionella pneumophila.

Authors:  Sandrine Lemaire; Klaudia Kosowska-Shick; Peter C Appelbaum; Gunther Verween; Paul M Tulkens; Françoise Van Bambeke
Journal:  Antimicrob Agents Chemother       Date:  2010-04-12       Impact factor: 5.191

9.  Antibacterial Properties of Four Novel Hit Compounds from a Methicillin-Resistant Staphylococcus aureus-Caenorhabditis elegans High-Throughput Screen.

Authors:  Nagendran Tharmalingam; Rajmohan Rajmuthiah; Wooseong Kim; Beth Burgwyn Fuchs; Elamparithi Jeyamani; Michael J Kelso; Eleftherios Mylonakis
Journal:  Microb Drug Resist       Date:  2018-02-20       Impact factor: 3.431

10.  Internalization of Staphylococcus aureus by human keratinocytes.

Authors:  Sompid Kintarak; Simon A Whawell; Paul M Speight; Samantha Packer; Sean P Nair
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.